RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE has filed 20 SEC Form 4 filings (137 transaction rows) across 1 company, with disclosures dating back to 2026. 20 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.
On the most recent filing, RUBINSTEIN JULIE is listed as President and COO at Adaptive Biotechnologies Corp. Inside the rolling window, RUBINSTEIN JULIE reported no open-market purchases and 54 open-market sales totaling $18.0M in ADPT. The largest disclosed transaction in the window is a sale of 141,583 ADPT shares on Mar 11, 2026, worth $1.9M.
Companies traded
Other insiders at ADPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$18.0M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ADPT | President and COO | Sale | 11,881 | $286K | Oct 21 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $291K | Oct 21 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $302K | Oct 21 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $305K | Oct 16 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $304K | Oct 16 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $288K | Oct 16 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $314K | Oct 13 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $303K | Oct 13 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $303K | Oct 13 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $330K | Oct 8 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $314K | Oct 8 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $305K | Oct 8 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $333K | Oct 6 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $334K | Oct 6 | SEC ↗ | |
| ADPT | President and COO | Sale | 11,881 | $347K | Oct 6 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,037 | $271K | Apr 29 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $269K | Apr 24 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $262K | Apr 24 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $267K | Apr 24 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $278K | Apr 21 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $277K | Apr 21 | SEC ↗ | |
| ADPT | President and COO | Sale | 30,941 | $454K | Apr 21 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $278K | Apr 16 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $278K | Apr 16 | SEC ↗ | |
| ADPT | President and COO | Sale | 19,060 | $270K | Apr 16 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has RUBINSTEIN JULIE made?
RUBINSTEIN JULIE has filed 20 SEC Form 4 filings (137 transaction rows) across 1 company since 2026.
Which companies does RUBINSTEIN JULIE trade?
RUBINSTEIN JULIE has filed SEC Form 4 disclosures for 1 company, including ADPT.
When was RUBINSTEIN JULIE's most recent SEC Form 4 filing?
RUBINSTEIN JULIE's most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.
What is RUBINSTEIN JULIE's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, RUBINSTEIN JULIE is listed as President and COO.
What is RUBINSTEIN JULIE's total buy and sell value in the current window?
Inside the rolling retention window, RUBINSTEIN JULIE bought $0 and sold $18.0M based on SEC Form 4 filings.
What was RUBINSTEIN JULIE's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 141,583 ADPT shares on 2026-03-11, worth $1.9M, per SEC Form 4 filings.